Additional file 2 of Association of DNA methylation with hypertension and blood pressure: a 7-year longitudinal study from KORA F4/FF4

Additional file 2: Table S1. Non-Significant CpG sites associated with HTN. Table S2. Significant CpG sites associated with SBP. Table S3. Significant CpG sites associated with DBP. Table S4. Non-Significant CpG sites associated with HTN from extended model. Table S5. Significant CpG sites associated with SBP from extended model. Table S6. Significant CpG sites associated with DBP from extended model. Table S7. Non-Significant CpG sites associated with HTN from repeated methylation measurements. Table S8. Non-Significant CpG sites associated with SBP from repeated methylation measurements. Table S9. Non-Significant CpG sites associated with DBP from repeated methylation measurements. Table S10. Significant CpG sites associated with interaction between HTN and follow-up time. Table S11. Significant CpG sites associated with interaction between SBP and follow-up time. Table S12. Significant CpG sites associated with interaction between DBP and follow-up time. Table S13. Non-Significant CpG sites associated with reversed HTN. Table S14. Significant CpG sites associated with persistent HTN. Table S15. Non-Significant CpG sites associated with progressed HTN. Table S16. Associated CpG-transcripts pairs.